Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.8700
0.00 (0.00%)
Jun 4, 2026, 8:07 AM CET
Epigenomics AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -0.31 | -3.35 | -4.46 | -17.3 | -2.43 |
Depreciation & Amortization | - | 0.01 | 1.35 | 7.02 | 0.34 |
Other Amortization | - | - | - | - | 0.08 |
Loss (Gain) From Sale of Assets | - | - | -0 | - | 0.01 |
Loss (Gain) From Sale of Investments | - | 2.28 | - | - | - |
Stock-Based Compensation | - | - | - | - | 0.1 |
Other Operating Activities | -0.01 | 0.23 | -2.63 | 1.47 | -1.26 |
Change in Accounts Receivable | - | - | - | - | 0.18 |
Change in Inventory | 0.03 | 0.11 | - | -1.86 | -0.05 |
Change in Accounts Payable | -0.01 | -0.47 | 0.38 | 0.25 | -1.19 |
Change in Unearned Revenue | - | - | - | - | -0.01 |
Change in Other Net Operating Assets | -0.23 | -0.02 | -0.35 | -0.2 | 0.09 |
Operating Cash Flow | -0.53 | -1.2 | -5.71 | -10.63 | -4.15 |
Capital Expenditures | - | - | - | -0.09 | -0.04 |
Sale of Property, Plant & Equipment | - | - | 0.03 | - | - |
Sale (Purchase) of Intangibles | - | - | - | -0.05 | - |
Investment in Securities | - | - | -0 | - | 0.98 |
Other Investing Activities | 0.02 | 0.03 | 0.04 | 0.1 | 0.01 |
Investing Cash Flow | 0.02 | 0.03 | 0.07 | -0.04 | 0.96 |
Long-Term Debt Issued | - | - | - | - | 22 |
Long-Term Debt Repaid | - | - | - | - | -0.27 |
Net Debt Issued (Repaid) | - | - | - | - | 21.73 |
Issuance of Common Stock | - | - | - | - | 2.17 |
Repurchase of Common Stock | - | - | -0.05 | - | - |
Other Financing Activities | - | - | -0.01 | -0.45 | -2.28 |
Financing Cash Flow | - | - | -0.06 | -0.45 | 21.62 |
Foreign Exchange Rate Adjustments | - | - | - | -0.02 | 1.06 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - |
Net Cash Flow | -0.51 | -1.18 | -5.7 | -11.14 | 19.48 |
Free Cash Flow | -0.53 | -1.2 | -5.71 | -10.71 | -4.19 |
Free Cash Flow Margin | -2220.83% | - | -1684.66% | -1191.77% | -67.50% |
Free Cash Flow Per Share | -0.61 | -1.37 | -6.69 | -13.17 | -7.47 |
Cash Interest Paid | - | - | - | 0.02 | 0.02 |
Cash Income Tax Paid | - | - | - | - | 0.02 |
Levered Free Cash Flow | -0.44 | -1.05 | -1.02 | -1.57 | -2.03 |
Unlevered Free Cash Flow | -0.44 | -1.05 | -1.02 | -1.52 | -2 |
Change in Working Capital | -0.21 | -0.38 | 0.04 | -1.81 | -0.99 |